First Time Loading...

Eagle Pharmaceuticals Inc
NASDAQ:EGRX

Watchlist Manager
Eagle Pharmaceuticals Inc Logo
Eagle Pharmaceuticals Inc
NASDAQ:EGRX
Watchlist
Price: 4.41 USD 0.23% Market Closed
Updated: May 6, 2024

Wall Street
Price Targets

EGRX Price Targets Summary
Eagle Pharmaceuticals Inc

Wall Street analysts forecast EGRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EGRX is 17 USD .

Lowest
Price Target
Not Available
Average
Price Target
17 USD
285% Upside
Highest
Price Target
Not Available
Eagle Pharmaceuticals Inc Competitors:
Price Targets
SVE
Synthaverse SA
41% Upside
603387
Getein Biotech Inc
298% Upside
PSTX
Poseida Therapeutics Inc
398% Upside
IMTX
Immatics NV
77% Upside
HRTX
Heron Therapeutics Inc
164% Upside
300676
BGI Genomics Co Ltd
145% Upside
300639
Guangdong Hybribio Biotech Co Ltd
540% Upside
APLT
Applied Therapeutics Inc
149% Upside

Revenue
Forecast

Revenue Estimate
Eagle Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Eagle Pharmaceuticals Inc's revenue is 42%. The projected CAGR for the next 3 years is -10%.

42%
Past Growth
-10%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Eagle Pharmaceuticals Inc

The compound annual growth rate of Eagle Pharmaceuticals Inc's operating income for the next 3 years is -21%.

N/A
Past Growth
-21%
Estimated Growth
Estimates Accuracy
-40%
Average Miss

Net Income
Forecast

Net Income Estimate
Eagle Pharmaceuticals Inc

The compound annual growth rate of Eagle Pharmaceuticals Inc's net income for the next 3 years is 4%.

N/A
Past Growth
4%
Estimated Growth
Estimates Accuracy
-51%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EGRX's stock price target?
Price Target
17 USD

According to Wall Street analysts, the average 1-year price target for EGRX is 17 USD .

What is Eagle Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
-10%

For the last 8 years the compound annual growth rate for Eagle Pharmaceuticals Inc's revenue is 42%. The projected CAGR for the next 3 years is -10%.

What is Eagle Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
-21%

The compound annual growth rate of Eagle Pharmaceuticals Inc's operating income for the next 3 years is -21%.

What is Eagle Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
4%

The compound annual growth rate of Eagle Pharmaceuticals Inc's net income for the next 3 years is 4%.